Keratoconus in Teenagers: A Parent's Guide to Stopping It

If your teenager has just been diagnosed with keratoconus, you need to know two things before anything else. It moves fastest at exactly this age. And it can be stopped, with a treatment that costs about two days of school.

Here’s the whole picture, in the order a parent needs it.

Why the teenage years are different

Keratoconus is a weakening of the cornea, the clear window at the front of the eye, that lets it bulge into a cone. In adults it often creeps. In teenagers it can run.

The evidence on this is consistent. When one large series compared children with adults at diagnosis, 27.8% of the children already had the most advanced stage of keratoconus, against 7.8% of the adults. And in a Zurich series of 59 eyes in patients aged 9 to 19, 88% of untreated eyes progressed within a year. Historically, being diagnosed young was one of the strongest predictors of eventually needing a corneal transplant.

That’s why I don’t apply an adult’s wait-and-see approach to a teenager. In a young patient, documented progression, or an already advanced map at the first visit, is reason enough to treat. Waiting for a second scan in six months can mean treating a worse cornea.

What parents notice first

Keratoconus in a teenager rarely announces itself. It usually shows up as a series of small things:

• Glasses that need changing every few months, with the astigmatism creeping up each time
• One eye noticeably worse than the other
• Squinting, or complaints that new glasses “still aren’t right”
• Glare, halos or ghosting around lights, especially at night
• Constant eye rubbing, often with hay fever, eczema or asthma in the background
• An optometrist mentioning “irregular astigmatism”, or that the retinoscope reflex looks odd

The diagnosis is made with corneal tomography, a three-dimensional map of the cornea’s shape and thickness. It’s painless, takes seconds, and picks up keratoconus long before a standard eye test can. If your teenager has any of the signs above, ask for that scan.

Eye rubbing: the one thing your family controls

Keratoconus is, to a large degree, a disease of eye rubbing. The cornea’s weakness makes it vulnerable, and rubbing is the force that pushes it out of shape. The evidence is striking. In one analysis, eye rubbing raised the odds of keratoconus fifteen-fold, atopy such as eczema or hay fever raised it five-fold, and the two together raised it more than fifty-fold. Among patients diagnosed before the age of 15, 92% had a history of eye rubbing, against 70% of those diagnosed as adults.

Rubbing is the only risk factor a family can change, and stopping it matters just as much after cross-linking as before, because it’s the main reason cross-linking occasionally fails in young patients. Practically:

• Treat the itch, not the habit. Almost every teenager who rubs has an allergic reason. Antihistamine and mast-cell-stabiliser drops, cold compresses and preservative-free lubricants take the itch away so there’s nothing to rub. My allergy management plan sets out exactly what to use.
• Watch the sleep position. Sleeping face down or with a hand pressed against the eye puts hours of pressure on the cornea every night. A back or side position with the eye clear of the pillow is the goal.
• Make it a household rule, not a nag. Teenagers respond better to understanding why than to being told off. Show them the map of their own cornea. It works.

Cross-linking: the treatment that stops it

Corneal cross-linking uses riboflavin, which is vitamin B2, and ultraviolet light to create new bonds between the collagen fibres of the cornea, stiffening it so the cone stops advancing. It’s the only treatment proven to halt keratoconus. A meta-analysis of 21 studies in children and adolescents found that cross-linking slowed or stopped progression across every technique studied, with the standard method also flattening the cone and improving vision.

The version I use is designed with school-aged patients in mind:

• Epi-on. The surface layer of the cornea is left intact rather than scraped off, using Glaukos Epioxa, which the US FDA approved in 2025 for patients aged 13 and over. No raw surface means far less pain and a recovery measured in days rather than weeks. I was the first surgeon in Australia to perform it.
• Topography-guided. On the Glaukos Mosaic system, the only one in Australia, the ultraviolet energy is concentrated on the cone itself rather than spread across the whole cornea. In my published series, 60% of patients improved their best corrected vision, which standard cross-linking isn’t designed to do.
• Asleep. Teenagers are lightly sedated or asleep for the procedure, with the eye numbed by drops. Nobody has to hold still for a bright light while awake.

What recovery looks like. The eye is gritty, light sensitive and uncomfortable for one to three days. I operate on a Thursday, and patients are back at school on the Monday, so the total cost is one and a half to two days of school. Vision fluctuates for a few weeks while the cornea settles and then steadies. There’s a fuller account in the cross-linking FAQ.

One thing to expect afterwards. Scans in the first twelve months move around as the cornea remodels. I don’t count anything inside that first year as progression, and I’d ask you not to panic at a six-month scan that looks a little different. Stability is judged from twelve months on.

If vision is already poor: CAIRS

Cross-linking stops the disease. It doesn’t undo a cone that has already advanced. For a teenager whose vision stays poor with glasses even once the cornea is stable, the next step is CAIRS, corneal allogenic intrastromal ring segments.

CAIRS are arcs of donor corneal tissue placed into channels in the cornea, where they push the cone back toward a regular shape and reduce the irregular astigmatism that glasses can’t correct. Because they’re human tissue rather than plastic, there’s nothing synthetic to erode or extrude in a cornea that has sixty years of life ahead of it, which is why I’m comfortable using them in teenagers. CAIRS can be combined with cross-linking, and a 2025 meta-analysis found significant improvements in both uncorrected and corrected vision with low complication rates. I’ll be straight with families that the published outcomes come from mixed-age series rather than adolescents specifically, and that this is most of what I do. It’s performed as a keratoplasty procedure that Medicare recognises, and teenagers are asleep for it.

Life with a stable cornea

Once the cornea is stabilised, most teenagers get on with things. Glasses often do the job in earlier disease; where the cornea is more irregular, a rigid or scleral contact lens gives excellent vision and teenagers adapt to them quickly. Sport is fine. Screens didn’t cause this and don’t need restricting. Driving later on depends on meeting the usual vision standard, which most treated patients do with glasses or lenses.

Two practical things help. Tell the school, so a seat near the front and larger print on screens are available without fuss. And have siblings scanned: first-degree relatives carry a substantially higher risk, early disease is invisible to a normal eye test, and a single tomography scan settles it.

The cost

Cross-linking for progressive keratoconus attracts a Medicare rebate. It can be done in the day hospital, or, for families without private health insurance, in our outpatient procedure room at the Queensland Eye Institute, which makes the most of the Medicare safety net. What cross-linking costs is set out separately, and so is why treating early is cheaper than the years of lenses, scans and eventual surgery that untreated progression brings.

The bottom line

Keratoconus in a teenager is urgent in a way it isn’t in an adult, and it’s also more fixable than it has ever been. Get the scan. Stop the rubbing. Cross-link the cornea before the cone advances, at a cost of two days of school. If vision has already been lost, CAIRS can rebuild the shape. Done in that order, most teenagers I see keep their vision for life.